Their findings confirm the described subtype-dependent effect on OS of delaying adjuvant chemotherapy: Time to chemotherapy 91 or more days was associated with an increased risk in breast cancer death among patients with TNBC but had no significant effect among patients with hormone receptor– positive tumors. Here, NR4A1 is linked to breast cancer.